The future of adjuvant chemotherapy for resected non-small cell lung cancer.

about

The future of adjuvant chemotherapy for resected non-small cell lung cancer.

Item

http://www.wikidata.org/entity/Q36066186

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

The future of adjuvant chemotherapy for resected non-small cell lung cancer.

@ast

The future of adjuvant chemotherapy for resected non-small cell lung cancer.

@en

type

Item

label

The future of adjuvant chemotherapy for resected non-small cell lung cancer.

@ast

The future of adjuvant chemotherapy for resected non-small cell lung cancer.

@en

prefLabel

The future of adjuvant chemotherapy for resected non-small cell lung cancer.

@ast

The future of adjuvant chemotherapy for resected non-small cell lung cancer.

@en

P1476

The future of adjuvant chemotherapy for resected non-small cell lung cancer.

@en

P2093

Johan F Vansteenkiste

http://www.w3.org/2001/XMLSchema#string

Rob H Schildermans

http://www.w3.org/2001/XMLSchema#string

P2860

Revisions in the International System for Staging Lung Cancer

A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung

Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial.

Fifteen-year follow-up of all patients in a study of post-operative chemotherapy for bronchial carcinoma

A phase II trial of oral tegafur and uracil plus cisplatin in patients with inoperable nonsmall cell lung cancer.

Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected].

Treatment of stage IIIA non-small cell lung cancer.

Multidisciplinary management of lung cancer.

Gefitinib (Iressa): a novel treatment for non-small cell lung cancer.

Treatment of non-small-cell lung cancer: a perspective on the recent advances and the experience with gefitinib.

P304

165-175

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737140.5.1.165

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2005-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15757448

http://www.w3.org/2001/XMLSchema#string